| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 115,171 | 121,830 | 116,092 | 105,461 | | Cost of Revenue | 34,765 | 37,131 | 35,257 | 32,493 | | | Gross Profit | 80,406 | 84,699 | 80,835 | 72,968 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,141 | 41,299 | 44,015 | 43,475 | | Non Recurring |
-
|
-
|
-
| 413 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,265 | 43,400 | 36,820 | 29,080 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (360) | 67 | (585) | 353 | | Earnings Before Interest And Taxes | 41,905 | 43,467 | 36,235 | 29,433 | | Interest Expense | 5,126 | 5,285 | 5,664 | 6,017 | | Income Before Tax | 36,779 | 38,182 | 30,571 | 23,416 | | Income Tax Expense | 13,351 | 13,952 | 11,005 | 6,701 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,428 | 24,230 | 19,566 | 16,715 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,428 | 24,230 | 19,566 | 16,715 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,428 | $24,230 | $19,566 | $16,715 |
|
0.51% Nasdaq 
Income Statement
